Request Deal Involvement

NEA led a $40m Series C funding round in Affinia Therapeutics.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Cooley

legal advisors

Cooley

KV Management

pr advisors

KV Management

or

Principals

ATLAS VENTURE LP

bidder

ATLAS VENTURE LP

AFFINIA THERAPEUTICS

target

AFFINIA THERAPEUTICS

AVIDITY PARTNERS

bidder

AVIDITY PARTNERS

NEW ENTERPRISE ASSOCIATES (NEA)

bidder

NEW ENTERPRISE ASSOCIATES (NEA)

ELI LILLY AND COMPANY

bidder

ELI LILLY AND COMPANY

ALEXANDRIA VENTURE INVESTMENTS

bidder

ALEXANDRIA VENTURE INVESTMENTS

F-PRIME CAPITAL

bidder

F-PRIME CAPITAL

GV (GOOGLE VENTURES)

bidder

GV (GOOGLE VENTURES)

MASS GENERAL BRIGHAM VENTURES

bidder

MASS GENERAL BRIGHAM VENTURES

PERCEPTIVE ADVISORS LLC

bidder

PERCEPTIVE ADVISORS LLC

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - NEA led a $40m Series C funding round in Affinia Therapeutics.